Showing results (411-420 of 2,556) with videos related to

Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|November 25, 2014
Cardiorenal syndrome type 2: from diagnosis to optimal managementRenato De Vecchis, Cesare Baldi
Therapeutics and Clinical Risk Management|November 4, 2014
Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case reportPetru Ifteni, Marius A Moga, Victoria Burtea, et al.
Therapeutics and Clinical Risk Management|November 18, 2020
Acute Imidacloprid Poisoning in ThailandCharuwan Sriapha, Satariya Trakulsrichai, Achara Tongpoo, et al.
Therapeutics and Clinical Risk Management|November 18, 2020
Cardiovascular Considerations in COVID19: A Comprehensive ReviewFaeze Keihanian, Leila Bigdelu
Therapeutics and Clinical Risk Management|November 19, 2020
Therapeutic Strategies for Mitigating Driving Risk in Patients with NarcolepsyCatherine A McCall, Nathaniel F Watson
Therapeutics and Clinical Risk Management|November 5, 2020
Inclisiran for the Treatment of Cardiovascular Disease: A Short Review on the Emerging Data and Therapeutic PotentialConstantine E Kosmas, Alba Muñoz Estrella, Andreas Skavdis, et al.
Therapeutics and Clinical Risk Management|September 5, 2020
Comparison of Adverse Event Profiles of Tumor Necrosis Factor-Alfa Inhibitors: Analysis of a Spontaneous Reporting DatabaseTomohito Wakabayashi, Keiko Hosohata, Saki Oyama, et al.
Therapeutics and Clinical Risk Management|September 5, 2020
Management Strategies of Patients with Neuromyelitis Optica Spectrum Disorder During the COVID-19 Pandemic EraSherif M Hamdy, Maged Abdel-Naseer, Hatem S Shehata, et al.
Therapeutics and Clinical Risk Management|November 25, 2020
Role of Arthrodiastasis Using Hinged Monolateral External Fixator Without Soft Tissue Release in Advanced Stage of Legg-Calve-Perthes DiseaseOmar Q Samarah, Abdullah Nimer, Fahed Al Karmi, et al.
Pageof 256